implantes mamarios

Schmitt, W; Eichhorn, M; Ford, R. D.
Journal of Plastic, Reconstructive & Aesthetic Surgery, 2016-01-01, Volúmen 69, Número 1, Páginas 55-60

portada - JPRAS - Vol. 69; No. 1 (2015)Augmentation mammaplasty is one of the most common surgical procedures performed by plastic surgeons. The aim of this study was to estimate the cost of the initial procedure and its subsequent complications, as well as project the cost of Food and Drug Administration (FDA)-recommended surveillance imaging.

Ventura, O.
Cir. plást. iberolatinoam. vol.43, no.1. ene./mar. 2016. pp.3-10

portada - Cirugía Plástica Ibero - Latinoamericana_hugeLa mama con disminución de volumen y ptósica requiere un procedimiento doble que consiste, en la mayoría de los casos, en aumento con implante y ajuste de los tejidos al nuevo tamaño. Esta es una realidad que sienten los cirujanos plásticos con experiencia y mucho más aquellos que comienzan a transitar por la especialidad.
En mamas ptósicas que requieren aumento, el volumen añadido de la prótesis puede cambiar los requerimientos de escisión cutánea, causando inconvenientes si se ha calculado mal la superficie desepidermizada o generando lógicas dudas entre una pexia con técnica periareolar o una periareolo-vertical.

Dinah, W; Rohrich, R.
Plastic and Reconstructive Surgery – Global Open: Post Editor Corrections: May 25, 2017

portada - PRS Golbal Open - Vol. 1; No. 3 (2013)The increasing variety of breast implants has led to their classification into «profile» types to guide implant cataloguing and selection. Implant «profile» describes the overall silhouette of the implant. It represents a permutation of all 3 dimensions of the implant: base diameter, projection, and volume. Implant «profile» is not the same as implant projection. Implant projection is a quantifiable linear measurement of the anterior-posterior dimension of the implant, whereas implant «profile» is a vendor-driven assessment that currently lacks universal standardization. Until «profile» assessments are standardized across vendors, it behooves us to be cognizant of their limitations as primary variables used to guide implant selection.

Brault, N. et als.
Journal of Plastic, Reconstructive & Aesthetic Surgery, 2017-05-01, Volúmen 70, Número 5, Páginas 585-595

portada - JPRAS - Vol. 70; No. 5 (2017)Breast implants and, more recently, autologous fat grafting are the two most common treatments used to correct tuberous breast deformity (TBD). The post-surgical quality of life between the two techniques is not well demonstrated. This study aimed to compare satisfaction and health-related quality of life in patients affected by TBD between these two techniques.
All TBD patients operated between January 2008 and May 2015 were retrospectively identified, and only those treated with implants or lipofilling were included. Satisfaction was evaluated at least 6 months after surgery with the postoperative Breast-Q ® augmentation module.

Doren, E. L. et als.
Plastic & Reconstructive Surgery – May 2017 – Volume 139 – Issue 9 – p 1042–1050

portada - PRS - Vol. 132; No. 2 (2013)Breast implant–associated anaplastic large cell lymphoma (ALCL) is a distinctive type of T-cell lymphoma that arises around breast implants. Although rare, all cases with adequate history have involved a textured breast implant. The objective of this study was to determine the U.S. incidence and lifetime prevalence of breast implant–associated ALCL in women with textured breast implants.
This study demonstrates a statistically significant association between textured breast implants and breast implant–associated ALCL. Although women with a textured breast implant have a low risk of developing breast implant–associated ALCL, the current U.S. incidence is significantly higher than that of primary ALCL of the breast in the general population.

Winocour, S. et als.
Journal of Plastic, Reconstructive & Aesthetic Surgery, 2014-01-01, Volúmen 67, Número 1, Pages 34-41

JPRAS - Vol. 67; No. 1 (2013)Pain in the early post-operative period following subpectoral placement of tissue expanders and implants is commonly reported. The current standard of care for pain control involves the use of oral narcotics. This study, determinated the efficacy of Botulinum toxin A (BTX-A) injections for pain relief following placement of subpectoral tissue expanders and breast implants.

Rocco, N. et als.
Cochrane Database of Systematic Reviews 2016 Issue 5. Art. No.: CD010895

logo Cochrane - small (fondo blanco)El cáncer de mama es el cáncer más frecuente en las mujeres en todo el mundo y es la principal causa de muerte por cáncer entre las mujeres. La mastectomía profiláctica o curativa a menudo está seguida por la reconstrucción de la mama, por lo que existen varios enfoques quirúrgicos que utilizan implantes de mama con los que los cirujanos pueden restaurar la apariencia, el tamaño y la forma natural de la mama. El objetivo de este trabajo fue evaluar los efectos de diferentes tipos de implantes de mama sobre la contractura capsular, las complicaciones quirúrgicas a corto y a largo plazo, el nivel de satisfacción posoperatoria y la calidad de vida en las pacientes sometidas al proceder.

Seigle-Murandi, F; Lefebvre, F; Bruant-Rodier, C; Bodin, F.
Journal of Plastic, Reconstructive & Aesthetic Surgery, 2017-01-01, Volúmen 70, Número 1, Pages 42-46

portada - JPRAS - Vol. 70; No. 1 (2016)The majority of studies assessing the rupture rate of breast implants were performed by the breast implant manufacturing industry with questionable independence. After repetitive removals of ruptured implants from the same model, our team decided to assess the rupture rate and the estimated risk thereof for most of the silicone gel–filled implants we have used since they regained market approval in France in 2001.